# Combined Renin Inhibition/Beta-blockade

> **NCT00627861** · NA · TERMINATED · sponsor: **The Rogosin Institute** · enrollment: 1 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Extended-release metoprolol

## Key facts

- **NCT ID:** NCT00627861
- **Lead sponsor:** The Rogosin Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The renin laboratory used in the study is no longer available.
- **Last updated:** 2015-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00627861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00627861, "Combined Renin Inhibition/Beta-blockade". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00627861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*